RxDoctor Payments Data

Patrick Henderson, MD

Psychiatry · Tulsa, OKNPI 1427403963

Payments from drug & device makers

$1,893in general payments, 2019–2025

Across 118 payments — averaging $16.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$280
  • Lundbeck LLC$260
  • Johnson & Johnson$253
  • Otsuka America Pharmaceutical, Inc.$240
  • Takeda Pharmaceuticals U.S.A., Inc.$202
  • Teva Pharmaceuticals USA, Inc.$157
  • plus $501 from 13 others

What the payments were for

  • Food & beverage$1,86398%
  • Education$302%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,893 in reported general payments places this provider in the 75th percentile of 328 psychiatry providers in Oklahoma.

See all psychiatry providers in Oklahoma

Medicare billing

Part B allowed, 2024
$26,196
Medicare patients
68
Services billed
213

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl43$64,035
RexultiBrexpiprazole19$41,065
Aripiprazole104$15,754
TrintellixVortioxetine Hydrobromide22$11,690
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl51$8,050
BelsomraSuvorexant17$6,802
Divalproex Sodium ErDivalproex Sodium17$3,750
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine89$3,452
Duloxetine Hcl86$3,077
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine34$3,023
Fluvoxamine Maleate34$2,315
Lamotrigine128$2,019
Lisdexamfetamine Dimesylate17$1,695
Paroxetine Hcl18$1,451
Bupropion XlBupropion Hcl68$1,392

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$280$64,03543 claims
Otsuka America Pharmaceutical, Inc.Rexulti$240$41,06519 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$202$11,69022 claims
Almatica Pharma LLCSertraline Hcl$18$48439 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 328 psychiatry providers in Oklahoma.

Other psychiatry in Tulsa

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →